Please assess the completion status of the following clinical trial:

Trial Title: Pharmacology of Aminophylline for Acute Kidney Injury in Neonates

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Neonate \< 3 months post natal age~* Diagnosed with acute kidney injury (AKI)~* Receiving aminophylline for AKI treatment as per local standard of care.~Exclusion Criteria:~* Presence of anatomical renal anomaly based on postnatal evaluation of the patient (hydronephrosis, multicystic kidney, renal agenesis, renal dysplasia, polycystic kidney, or obstructive uropathy)~* Patient on renal replacement therapy~* Major genetic abnormalities (trisomy 13, 18 or 21).

- Gender: ALL
- Minimum Age: None
- Maximum Age: 3 Months
- Healthy Volunteers: f

Study Arms:
- Aminophylline per standard of care (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).